Testimonies and Statements by NCHR

The articles in this section focus on NCHR’s testimonies that have been presented at FDA and other meetings. If you want to learn more about the debate around breast implant safety click on a link to learn more. To see more testimonies visit Other Testimonies about Breast Implant Complications

2020

Guidance for easy-to-understand information for FDA black box warning and Patient Informed Consent Check List

2019

Comment on General and Plastic Surgery Devices Panel of the Medical Devices Advisory Committee; Notice of Meeting [FDA-2019-N-0426]

2018

MD Anderson Study of 100,000 Women Linking Breast Implants to Autoimmune Disorders

2017

American Health Care Act

2013

FDA Approval of Natrelle 410 Implants

2011

FDA Hearing on Silicone Gel Breast Implants

2007

2006

FDA Approval of Silicone Gel Implants

Canadian Parliament’s Consideration of Silicone Breast Implants

 

2005

FDA Consideration of Silicone Breast Implants

2003

FDA Approval of Inamed’s Silicone Gel Breast Implants

FDA Hearing on Silicone Gel Breast Implants

2002

FDA Hearing on Saline Breast Implants

2000

FDA Approval of Mentor and Inamed Saline Breast Implants